In a clinical trial in Burkina Faso, the Matrix-M vaccine -- developed by the University of Oxford's Jenner Institute -- was found to be 77 percent effective after 450 infants inoculated in 2019 were followed up for a year, the Oxford researchers said in a statement.
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/32KC8HE
https://ift.tt/eA8V8J
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/32KC8HE
https://ift.tt/eA8V8J
Post a Comment